Evidence Strategy

Navigate the complexities of evidence strategy

Leverage a dedicated team of subject matter experts to build evidence, drive scientific and medical education, support value-based pricing, and achieve favorable market access.

High-quality, compelling evidence

In today’s global life sciences marketplace, evidence is critical. Novel therapies—especially high-value therapeutics and specialty drugs—requires compelling evidence to influence physicians’ prescribing behavior and persuade payers to provide access to label.

Pre-launch, HEOR teams characterize the disease landscape, identify unmet needs, create medical education, and conduct market-shaping activities.

Post-launch, therapies must continue to generate proof of real-world value, especially in competitive therapeutic areas where the evidence demonstrates superiority. Without high-quality evidence, commercial objectives suffer, market access becomes sub-optimal, Key Opinion Leader advocacy is diminished, and a product’s potential may be limited.

Comprehensive HEOR & Evidence Strategy

Access a complete suite of Health Economics and Outcomes Research (HEOR) services to differentiate product value, demonstrate must-have evidence, and support scientific dissemination. Trinity’s deep expertise spans Evidence Planning, Evidence Generation and Execution, and Scientific Dissemination—flowing across eight core engagement types.

Trinity has helped hundreds of clients answer key business questions, including:

Unmet Need

What are the unmet needs and epidemiology in the current treatment paradigm? How effective are the therapies in this market or class?

Treatment Patterns

What are the treatment patterns, therapy use, and behaviors surrounding switching or adherence?

Cost of Care

What is the overall Healthcare Resource Utilization (HCRU)? What is the holistic cost of care?

Pain Points & Gaps

Where are the pain points and gaps for a treatment to add value?

Our Impact

Proven expertise in high-value therapies: Provide specialized knowledge for Pharma, Biotech, and MedTech therapies with high unmet need.
Deep familiarity with first-to-market launches: Offer expertise for life-saving products, including those for pediatric conditions and rare diseases.
Creative, impactful evidence differentiation: Enable clients to stand out in competitive therapeutic areas through unique, data-driven insights.
Stellar track record: Partner to conduct Real World Evidence (RWE) studies, publish results, and translate findings into market access and strategic pricing support.

Proven Process, Tech-Enabled Evidence

Leverage best-in-class, scientifically driven, publication-quality research methods to demonstrate asset value at every lifecycle stage. Trinity helps identify the right patients using advanced data, analytics, and rigor, driving robust evidence with direct data access. Our integrated, tech-enabled approach connects clients with dedicated HEOR and RWE teams for support.

Work with a team of advanced degree experts (including multiple PhD holders), who consistently deliver high-quality insights and products to meet stakeholder needs.